QuickStart Program
KalVista Cares may help eligible patients with temporary treatment options while awaiting coverage determination.*
This website is intended for US residents.
Living with HAE can bring unique challenges, and at KalVista Cares, we understand how important it is to feel supported. That’s why our dedicated Care Managers are here to help ensure you have the treatment you need, when you need it.
Navigate insurance coverage and minimize delays in accessing EKTERLY.
Evaluate your eligibility for financial support programs that
may help cover the
cost of EKTERLY.
Work with your specialty pharmacy to help ensure you receive your treatment.
Connect to educational resources and HAE advocacy groups.
KalVista Cares may help eligible patients with temporary treatment options while awaiting coverage determination.*
KalVista Cares may help eligible patients with temporary treatment options while awaiting coverage determination.*
*For new patients only.
The KalVista Cares Co-Pay Assistance Program may help lower out-of-pocket costs for eligible patients prescribed EKTERLY.
To be eligible, you must:
Your Care Manager will review your insurance coverage with you and determine if
you are eligible for
the KalVista Cares
Co-Pay Assistance Program.†‡
†Terms and conditions apply.
‡IMPORTANT NOTICE: This co-pay assistance program is intended only for eligible patients with commercial (private) insurance. Patients with government-funded insurance, such as Medicare, Medicaid, TRICARE, or any state or federal health insurance program, are not eligible to participate. Participation in the program is subject to eligibility requirements and program limits. The program may cover a portion or all of the patient’s out-of-pocket costs up to a maximum amount determined by the program. Terms and conditions may change from time to time, or the program may be discontinued at any time without notice. By participating, patients agree to comply with all terms and conditions.
If you're interested in EKTERLY, your healthcare provider can help determine whether EKTERLY may
be right for you. Download the
Doctor Discussion Guide to help inform those
conversations.
Our team is available at
1-844-432-3322
Monday-Friday between 8:30 am-8 pm ET.
ELLIS, real EKTERLY patient
EKTERLY is a prescription medicine used to treat sudden (acute) attacks of hereditary angioedema (HAE) in adults and children aged 12 years of age and older. It is not known if EKTERLY is safe and effective in children under 12 years of age.
Before taking EKTERLY, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking EKTERLY with certain other medicines can cause side effects or affect how well EKTERLY or the other medicines work. Especially tell your healthcare provider if you take any of the following, as their use with EKTERLY is not recommended: itraconazole, phenytoin, efavirenz.
Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
The most common side effects of EKTERLY include headache. For more information, ask your healthcare provider or pharmacist. Talk to your doctor for medical advice about side effects.
You are encouraged to report side effects related to KalVista products by calling 1-855-258-4782. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information, including Patient Information.